Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Esclama
2. K 1900
3. K-1900
4. K1900
5. Naxogin
6. Nitrimidazine
7. Nulogyl
1. 6506-37-2
2. Naxogin
3. Nitrimidazine
4. Nimorazol
5. Nulogyl
6. Esclama
7. Naxofem
8. 4-(2-(5-nitro-1h-imidazol-1-yl)ethyl)morpholine
9. Acterol
10. Acterol Forte
11. 4-[2-(5-nitroimidazol-1-yl)ethyl]morpholine
12. Nimorazolo
13. Sirledi
14. K-1900
15. N-2-morpholinoethyl-5-nitroimidazole
16. 1-(2-n-morpholinylethyl)-5-nitroimidazole
17. Morpholine, 4-[2-(5-nitro-1h-imidazol-1-yl)ethyl]-
18. Nsc 107524
19. 4-(2-(5-nitroimidazol-1-yl)ethyl)morpholine
20. Nsc-107524
21. 4-[2-(5-nitro-1h-imidazol-1-yl)ethyl]morpholine
22. Morpholine, 4-(2-(5-nitro-1h-imidazol-1-yl)ethyl)-
23. Mls002703984
24. 469ulx0h4g
25. Morpholine, 4-(2-(5-nitroimidazol-1-yl)ethyl)-
26. Nimorazole (inn)
27. Nimorazolum
28. Nimorazole [inn]
29. 1-(.beta.-morpholinoethyl)-5-nitroimidazole
30. Morpholine, 4-[2-(5-nitroimidazol-1-yl)ethyl]-
31. Nimorazolo [dcit]
32. Nimorazol [inn-spanish]
33. Nimorazolum [inn-latin]
34. K 1900
35. 1-(beta-morpholinoethyl)-5-nitroimidazole
36. 1-(n-p-ethylmorpholine)-5-nitroimidazole
37. Nimorazole [inn:ban]
38. Einecs 229-394-4
39. 4-(2-(5-nitroimidazol-1-yl)ethyl)-morpholine
40. Brn 0533758
41. Unii-469ulx0h4g
42. Naxogin (tn)
43. Nimorazole [mi]
44. Nimorazole [mart.]
45. Dsstox_cid_31584
46. Dsstox_rid_97468
47. Nimorazole [who-dd]
48. Dsstox_gsid_57795
49. Schembl21836
50. Chembl435966
51. Dtxsid1057795
52. Chebi:134929
53. Bcp11055
54. Tox21_113897
55. Mfcd00866796
56. Nsc107524
57. S6411
58. Zinc26167988
59. Akos022174968
60. Db12172
61. Ncgc00261977-01
62. Ac-35227
63. Am807557
64. As-31120
65. Da-21636
66. Hy-16349
67. Smr001570693
68. Cas-6506-37-2
69. Wln: T6n Dotj A2- At5n Cnj Enw
70. Ft-0710009
71. A13091
72. D07352
73. 506n372
74. A834961
75. Q7037737
76. 4-[2-(5-nitro-1h-imidazol-1-yl)ethyl]morpholine #
| Molecular Weight | 226.23 g/mol |
|---|---|
| Molecular Formula | C9H14N4O3 |
| XLogP3 | -0.4 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 3 |
| Exact Mass | 226.10659032 g/mol |
| Monoisotopic Mass | 226.10659032 g/mol |
| Topological Polar Surface Area | 76.1 Ų |
| Heavy Atom Count | 16 |
| Formal Charge | 0 |
| Complexity | 239 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Antitrichomonal Agents
Agents used to treat trichomonas infections. (See all compounds classified as Antitrichomonal Agents.)
P - Antiparasitic products, insecticides and repellents
P01 - Antiprotozoals
P01A - Agents against amoebiasis and other protozoal diseases
P01AB - Nitroimidazole derivatives
P01AB06 - Nimorazole
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?
